10x Genomics, Inc.
A life-sciences technology company that makes instruments, consumables, and software for studying biology at the level of individual cells and their spatial context, using its Chromium and Visium platforms. Founded in 2012 in Pleasanton, California, by Serge Saxonov, Ben Hindson, and Kevin Ness, the company's name reflects their goal of a ten-fold, or "10x," improvement in biological resolution rather than incremental progress.
Bought 187.5K · Sold 2.20M
Sold 1.00M
Sold 1.01M
Granted 1.07M · Sold 587.7K
Granted 4.6K · Bought 300.0K · Sold 3.10M
Granted 1.47M · Sold 979.5K
Granted 37.4K · Sold 255.0K
Granted 442.2K · Sold 79.5K
Granted 213.3K · Sold 33.0K
Granted 389.3K · Bought 158 · Sold 248.7K
Granted 505.2K · Bought 158 · Sold 409.4K
Granted 45.9K · Bought 40.0K
Granted 110.4K · Sold 28.2K
Granted 72.4K · Sold 15.0K
Granted 37.4K
Granted 43.2K · Sold 7.6K
Granted 37.4K · Sold 7.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Tananbaum James B. +4 co-filers10% owner · 28 transactions | — | 11.96Mas of May 2020 | — | 187.5K | 2.20M |
| Steed Michael Robert +7 co-filers10% owner · 5 transactions | — | 10.16Mas of Apr 2020 | — | — | 1.00M |
| Venrock Associates VI, L.P. +3 co-filers10% owner · 8 transactions | — | 7.83Mas of Dec 2020 | — | — | 1.01M |
| Saxonov SergeChief Executive Officer, Director · 290 transactions | — | 4.40M | 1.07M | — | 587.7K |
| Roberts Bryan EDirector · 18 transactions | — | 4.29Mas of Jun 2023 | 4.6K | 300.0K | 3.10M |
| SB Investment Advisers (Uk) LTD +1 co-filer10% owner · 1 transaction | — | 3.84Mas of Feb 2020 | — | — | — |
| Hindson Benjamin J.See Remarks, Director · 218 transactions | — | 488.2K | 1.47M | — | 979.5K |
| Stuelpnagel John RDirector · 196 transactions | — | 368.4K | 37.4K | — | 255.0K |
| Taich AdamChief Financial Officer · 9 transactions | — | 362.7K | 442.2K | — | 79.5K |
| Mammen MathaiDirector · 6 transactions | — | 180.3Kas of Jun 2024 | 213.3K | — | 33.0K |
| McAnear Justin J.Former Chief Financial Officer · 183 transactions | — | 143.2Kas of Aug 2024 | 389.3K | 158 | 248.7K |
| Crutchfield BradfordChief Commercial Officer · 179 transactions | — | 97.2Kas of May 2022 | 505.2K | 158 | 409.4K |
| Mateo AlanDirector · 4 transactions | — | 85.9K | 45.9K | 40.0K | — |
| Wilbur JamesChief Commercial Officer · 6 transactions | — | 83.3Kas of Nov 2023 | 110.4K | — | 28.2K |
| Kosaraju SridharDirector · 47 transactions | — | 68.3K | 72.4K | — | 15.0K |
| Popovits Kimberly JDirector · 6 transactions | — | 37.4K | 37.4K | — | — |
| Teichmann Sarah A.Director · 4 transactions | — | 35.6K | 43.2K | — | 7.6K |
| Suliman ShehnaazDirector · 10 transactions | — | 29.5K | 37.4K | — | 7.9K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -9.44M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.